Literature DB >> 14725638

Disruption of self-organized actions in monkeys with progressive MPTP-induced parkinsonism: II. Effects of reward preference.

Mathias Pessiglione1, Dominique Guehl, Caroline Jan, Chantal François, Etienne C Hirsch, Jean Féger, Léon Tremblay.   

Abstract

The motor and cognitive symptoms of Parkinson's disease (PD) are well documented, but little is known about the functionality of motivational processes mediated by the limbic circuits of basal ganglia. The aim of this study was to test the ability of motivational processes to direct and to urge behaviour, in four vervet monkeys (Cercopithecus aethiops) progressively intoxicated with systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) injections (0.3-0.4 mg/kg every 4-7 days). In the food preference task, the monkeys had to retrieve two types of directly visible food, simultaneously available in the wells of a reward board. At all stages of MPTP-induced parkinsonism, the monkeys continued to take their favourite food first. In the symbol discrimination task, the wells were covered with sliding plaques cued by symbols indicating the absence or presence of a reward, and the different types of food were blocked in separate sessions. Monkeys with mild or moderate parkinsonism made fewer attempts and took longer to retrieve non-preferred compared with preferred rewards. These results indicate that motivational processes are still able to direct (food preference task) and to urge (symbol discrimination task) behaviour in MPTP-lesioned monkeys. Such a functional preservation may be related to the relatively spared dopaminergic innervation of the limbic circuits that we found in our monkeys, in agreement with the literature on humans. Furthermore, the frequency of executive disorders (such as hesitations and freezing) appeared to be much lower with the preferred rewards. Thus, the preserved motivational processes may help to overcome executive dysfunction in the early stages of human PD.

Entities:  

Mesh:

Year:  2004        PMID: 14725638     DOI: 10.1111/j.0953-816x.2003.03089.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  6 in total

1.  Motor cortex stimulation: mild transient benefit in a primate model of Parkinson disease.

Authors:  Alex K Wu; Kevin W McCairn; Gabriel Zada; Tiffany Wu; Robert S Turner
Journal:  J Neurosurg       Date:  2007-04       Impact factor: 5.115

Review 2.  Dopamine and serotonin modulation of motor and non-motor functions of the non-human primate striato-pallidal circuits in normal and pathological states.

Authors:  Véronique Sgambato-Faure; Léon Tremblay
Journal:  J Neural Transm (Vienna)       Date:  2017-02-07       Impact factor: 3.575

3.  Cortical Serotonergic and Catecholaminergic Denervation in MPTP-Treated Parkinsonian Monkeys.

Authors:  Gunasingh Jeyaraj Masilamoni; Allison Weinkle; Stella M Papa; Yoland Smith
Journal:  Cereb Cortex       Date:  2022-04-20       Impact factor: 4.861

Review 4.  Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.

Authors:  Gunasingh J Masilamoni; Yoland Smith
Journal:  J Neural Transm (Vienna)       Date:  2017-08-31       Impact factor: 3.575

5.  Why don't you try harder? An investigation of effort production in major depression.

Authors:  Marie-Laure Cléry-Melin; Liane Schmidt; Gilles Lafargue; Nicolas Baup; Philippe Fossati; Mathias Pessiglione
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

Review 6.  Animal models of Parkinson's disease: a guide to selecting the optimal model for your research.

Authors:  Joana Lama; Yazead Buhidma; Edward J R Fletcher; Susan Duty
Journal:  Neuronal Signal       Date:  2021-12-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.